Pharmarise Holdings: Notice regarding the review of the medium-term management plan
Pharmarise Holdings: Notice regarding the setting of materiality KPIs
Pharmarise Holdings: About some of today's reports
Pharmarise Holdings: Legal post-facto disclosure documents (company split) (NEXT PH Co., Ltd.)
Pharmarise Holdings: Notice regarding the opening of a new pharmacy
Pharmarise Holdings: Notice regarding pharmacy business transfer
Pharmarise Holdings: Notice Concerning Borrowing of Funds
Pharmarise Holdings: Legal Advance Disclosure Documents (Company Split) (NEXT PH Co., Ltd.)
Pharmarise Holdings: Notice regarding the company split (simple absorption split) into a subsidiary due to the transfer of part of the business from the Kanichi Shoten Group
Pharmarise Holdings: Notice regarding the details of shareholder benefits
Pharmarise Holdings: [Delayed]Consolidated Financial Results for the First Three Months of the Fiscal Year Ending May 31, 2025 (Japan GAAP)
Pharmarise Holdings: Notice regarding partial business transfer from Kanichi Shoten Group
Pharmarise Holdings: Notice regarding the aggregated results of the exercise of voting rights at the 38th Annual General Meeting of Shareholders
Pharmarise Holdings: Matters relating to controlling shareholders, etc.
Pharmarise Holdings: Independent Company Executives Declaration
Pharmarise Holdings: Announcements of individual stocks regarding the revision of the mid-term management plan.
Pharmarise Holdings: Announcements of organizational changes and personnel changes
Pharmarise Holdings: Announcements of individual stocks regarding the opening of a new pharmacy.
Pharmarise Holdings: Announcements of company executives personnel
Pharmarise Holdings: [Extension] Consolidated financial statements (Japan standards) for the fiscal year ended May 31, 2024.